The shape-shifting telehealth company has spent the past year trying to cash in on GLP-1s, the hottest drug to hit weight loss in decades. It could all slip away. By Madison Muller and Devin Leonard

Trump’s Unapologetic Emissary
35:24

Where Does Spirit Airlines Go When It Dies?
29:32

Myanmar: The War the World Forgot
42:08